US Patent Issued to KAINOS MEDICINE on Sept. 29 for "Fas-associated factor 1 (FAF1)-loaded exosomes and use thereof as anti-cancer agent" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,271, issued on Sept. 29, was assigned to KAINOS MEDICINE INC. (Seongnam-si, South Korea).

"Fas-associated factor 1 (FAF1)-loaded exosomes and use thereof as anti-cancer agent" was invented by Eunhee Kim (Seoul, South Korea) and Jeong-Hoon Han (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Fas-associated factor 1 (FAF1) protein-loaded exosomes and a cancer treatment using FAF1 protein-loaded exosomes are disclosed. FAF1 protein-loaded exosomes are isolated from HEK 293 cells in which FAF1 having a known tumor-suppressive function is overexpressed and administered the FAF1 protein-loaded exosomes to various tumor models in w...